Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Immune Science is a clinical-stage biotechnology company based in Beijing, China, focused on developing next-generation cell therapies for solid tumors. The company utilizes proprietary genetic engineering platforms to create advanced CAR-T and TCR-T candidates designed to penetrate and function within the challenging microenvironment of solid malignancies. Its lead programs target well-validated antigens such as GPC3 and Mesothelin, with clinical trials currently evaluating their safety and efficacy in patients with liver and pancreatic cancers. Founded by renowned immunologist Dr. Li Luyuan, Green Immune Science integrates academic research with industrial development to advance the field of cancer immunotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 格林免疫科学.